eric topol glp 1 SUPER AGERS (Part 2): on Sleep, GLP-1s, and AI Straight Talk with Daniel Drucker

However, these results also introduce a practical challenge: the risk of cross-resistance when patients receive more than one ADC with the same payload mechanism

Chetan Ahya: And 10pm in Hong Kong Seth Carpenter: Since our last roundtable in April, the global economy has continued to face all sorts of shocks, a mix of resilience and friction

Epigallocatechin-3-gallate at the nanoscale: a new strategy for cancer treatment

: 32

Future research should prioritize prospective validation of signals, pharmacokinetic interactions, and obesity-cancer doseresponse relationships to optimize diabetes management strategies

Glucagon-like peptide-1 inhibits prandial gastrointestinal motility through myenteric neuronal mechanisms in humans